Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Dec 6:11:903.
doi: 10.1186/1471-2458-11-903.

Design and study protocol of the maternal smoking cessation during pregnancy study, (M-SCOPE)

Andriani N Loukopoulou  1 , Constantine I Vardavas, George Farmakides, Christos Rossolymos, Charalambos Chrelias, Manolis N Tzatzarakis, Aristidis Tsatsakis, Maria Lymberi, Gregory N Connolly, Panagiotis K Behrakis
Affiliations
Randomized Controlled Trial

Design and study protocol of the maternal smoking cessation during pregnancy study, (M-SCOPE)

Andriani N Loukopoulou et al. BMC Public Health. .

Abstract

Background: Maternal smoking is the most significant cause of preventable complications during pregnancy, with smoking cessation during pregnancy shown to increase birth weight and reduce preterm birth among pregnant women who quit smoking. Taking into account the fact that the number of women who smoke in Greece has increased steadily throughout the previous decade and that the prevalence of smoking among Greek females is one of the highest in the world, smoking cessation should be a top priority among Greek health care professionals.

Methods/design: The Maternal Smoking Cessation during Pregnancy Study (M-SCOPE), is a Randomized Control Trial (RCT) that aims to test whether offering Greek pregnant smokers a high intensity intervention increases smoking cessation during the third trimester of pregnancy, when compared to a low intensity intervention. Prospective participants will be pregnant smokers of more than 5 cigarettes per week, recruited up to the second trimester of pregnancy. Urine samples for biomarker analysis of cotinine will be collected at three time points: at baseline, at around the 32nd week of gestation and at six months post partum. The control group/low intensity intervention will include: brief advice for 5 minutes and a short leaflet, while the experimental group/intensive intervention will include: 30 minutes of individualized cognitive-behavioural intervention provided by a trained health professional and a self-help manual especially tailored for smoking cessation during pregnancy, while counselling will be based on the ''5 As.'' After childbirth, the infants' birth weight, gestational age and any other health related complications during pregnancy will be recorded. A six months post-partum a follow up will be performed in order to re-assess the quitters smoking status.

Discussion: If offering pregnant smokers a high intensity intervention for smoking cessation increases the rate of smoking cessation in comparison to a usual care low intensity intervention in Greek pregnant smokers, such a scheme if beneficial could be implemented successfully within clinical practice in Greece.

Trial registration: ClinicalTrials.gov Identifier NCT01210118.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study Design Flowchart.
See this image and copyright information in PMC

References

    1. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER package. Geneva, Switzerland; 2008. http://www.who.int/tobacco/mpower/mpower_report_full_2008.pdf
    1. Hayashi Τ. In: UICC smoking control workshop. Suketami Tominanga, Kunio Aoki, editor. University of Nagoya Press Nagoya, Japan; 1979. Legislation and antismoking social attitudes in Japan.
    1. Peto R, Lopez AD, Boreham J, Thun M, Heath C, Doll J, Doll R. Mortality from smoking worldwide. Brit Med Bul. 1996;52(suppl 1):12–21. - PubMed
    1. Ezzati M, Lopez AD. Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control. 2004;13:388–395. doi: 10.1136/tc.2003.005215. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention. Annual Smoking-Attributable Mortality, Years of Potential Life Lost, and Productivity Losses--United States, 1997-2001. MMMR. 2002;51(suppl 14):300–303. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5114a2.htm

Publication types

Associated data